吴承翰 / Wu Chenghan

Overview

吴承翰 / Wu Chenghan is the neurosurgery-trained guest in 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32, discussing optogenetics, functional neurosurgery, psychiatry, and neurotechnology ethics.

Current Profile

The source presents Wu as a former neurosurgical clinician and researcher whose Stanford period brought him into contact with Karl Deisseroth and the surrounding laboratory community. His contribution is translational: he explains why causal circuit manipulation is more informative than observation alone while repeatedly separating animal behavior from human subjective experience and experimental precision from routine clinical readiness.

He also connects technical power to clinical obligation. Historical psychosurgery, medication, TMS, deep-brain stimulation, optogenetics, and future diagnostic tools are evaluated through severity, reversibility, target knowledge, individual variability, informed consent, and the possibility that treatment could become control.

Key Characteristics

• Combines neurosurgical clinical experience with neuroscience research framing.
• Explains optogenetics as a causal experimental method rather than a routine psychiatric cure.
• Preserves the inference boundary between animal behavior and human subjective experience.
• Distinguishes treatment efficacy from proof of disease cause.
• Treats autonomy and personality continuity as part of neurotechnology safety.

Evidence

• Clinical and research background - 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32 describes his earlier neurosurgical practice and research and his Stanford contact with Deisseroth’s group.
• Causal-method explanation - 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32 has him contrast observational correlation with selective activation or inhibition followed by behavioral measurement.
• Translation boundary - 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32 repeatedly distinguishes mouse behavioral assays from human feelings, diagnoses, and individualized treatment.
• Clinical ethics - 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32 connects feeding, aggression, desire, and personality-relevant manipulation to consent, agency, and the treatment-control boundary.

Qualifications

This profile is based on one podcast summary rather than an independent biography, credentials review, publication record, or clinical assessment. Institutional relationships, research roles, experiment descriptions, trial stages, and treatment claims remain source-scoped. The episode is public education, not individualized medical guidance.

What Changed

• Created the profile around Wu’s causal-inference, clinical-translation, and neuroethics framing.

Relationships

• What’s Next｜科技早知道 - show carrying the conversation.
• 声东击西 - crossover partner named in the episode title.
• 雅贤 - discussion partner whose name appears as 雅娴 in the new source.
• Karl Deisseroth - researcher and author central to the episode’s account.
• Optogenetics - principal experimental technology Wu explains.
• Psychiatry Measurement Gap - clinical measurement problem he highlights.
• Neurotechnology Agency Boundary / 神经技术能动性边界 - ethical boundary developed from his examples.